228 related articles for article (PubMed ID: 32716953)
1. Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data.
Iljicsov A; Milanovich D; Ajtay A; Oberfrank F; Bálint M; Dobi B; Bereczki D; Simó M
PLoS One; 2020; 15(7):e0236432. PubMed ID: 32716953
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.
Höer A; Schiffhorst G; Zimmermann A; Fischaleck J; Gehrmann L; Ahrens H; Carl G; Sigel KO; Osowski U; Klein M; Bleß HH
BMC Health Serv Res; 2014 Sep; 14():381. PubMed ID: 25209585
[TBL] [Abstract][Full Text] [Related]
3. The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
Marrie RA; Yu N; Blanchard J; Leung S; Elliott L
Neurology; 2010 Feb; 74(6):465-71. PubMed ID: 20071664
[TBL] [Abstract][Full Text] [Related]
4. Validation of multiple sclerosis diagnoses in the Swedish National Patient Register.
Murley C; Friberg E; Hillert J; Alexanderson K; Yang F
Eur J Epidemiol; 2019 Dec; 34(12):1161-1169. PubMed ID: 31493189
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis incidence and prevalence in Poland: Data from administrative health claims.
Wnuk M; Maluchnik M; Perwieniec J; Podwojcic K; Szelag M; Walkiewicz D; Zakrzewski M; Kulakowska A; Brola W; Rejdak K; Slowik A
Mult Scler Relat Disord; 2021 Oct; 55():103162. PubMed ID: 34332458
[TBL] [Abstract][Full Text] [Related]
6. Linking Individual Patient Data to Estimate Incidence and Prevalence of Parkinson's Disease by Comparing Reports of Neurological Services and Pharmacy Prescription Refills at a Nationwide Level.
Szatmári S; Ajtay A; Bálint M; Takáts A; Oberfrank F; Bereczki D
Front Neurol; 2019; 10():640. PubMed ID: 31275231
[No Abstract] [Full Text] [Related]
7. Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan.
Al-Sakran LH; Marrie RA; Blackburn DF; Knox KB; Evans CD
Can J Neurol Sci; 2018 May; 45(3):295-303. PubMed ID: 29557321
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada.
Widdifield J; Ivers NM; Young J; Green D; Jaakkimainen L; Butt DA; O'Connor P; Hollands S; Tu K
Mult Scler; 2015 Jul; 21(8):1045-54. PubMed ID: 25392338
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prevalence of MS in children: A population-based study in Ontario, Canada.
Marrie RA; O'Mahony J; Maxwell C; Ling V; Yeh EA; Arnold DL; Bar-Or A; Banwell B;
Neurology; 2018 Oct; 91(17):e1579-e1590. PubMed ID: 30258022
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data.
Foulon S; Maura G; Dalichampt M; Alla F; Debouverie M; Moreau T; Weill A
J Neurol; 2017 Jun; 264(6):1185-1192. PubMed ID: 28516332
[TBL] [Abstract][Full Text] [Related]
11. The incidence and prevalence of thyroid disease do not differ in the multiple sclerosis and general populations: a validation study using administrative data.
Marrie RA; Yu BN; Leung S; Elliott L; Warren S; Wolfson C; Tremlett H; Fisk J; Blanchard J
Neuroepidemiology; 2012; 39(2):135-42. PubMed ID: 22889755
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of multiple sclerosis in Csongrád County, Hungary.
Zsiros V; Fricska-Nagy Z; Füvesi J; Kincses ZT; Langane E; Paulik E; Vécsei L; Bencsik K
Acta Neurol Scand; 2014 Nov; 130(5):277-82. PubMed ID: 24611546
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Nervous System: Parkinson's Disease, Multiple Sclerosis, and Epilepsy.
Canova C; Danieli S; Barbiellini Amidei C; Simonato L; Di Domenicantonio R; Cappai G; Bargagli AM
Epidemiol Prev; 2019; 43(4 Suppl 2):62-74. PubMed ID: 31650807
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation.
Carod-Artal FJ
Mult Scler Relat Disord; 2021 Jan; 47():102657. PubMed ID: 33302230
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis incidence in Tuscany from administrative data.
Bezzini D; Policardo L; Profili F; Meucci G; Ulivelli M; Bartalini S; Francesconi P; Battaglia MA
Neurol Sci; 2018 Nov; 39(11):1881-1885. PubMed ID: 30090983
[TBL] [Abstract][Full Text] [Related]
16. The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada.
Marrie RA; Fisk JD; Stadnyk KJ; Yu BN; Tremlett H; Wolfson C; Warren S; Bhan V;
Can J Neurol Sci; 2013 Nov; 40(6):824-31. PubMed ID: 24257224
[TBL] [Abstract][Full Text] [Related]
17. Risk of cancer among Finnish multiple sclerosis patients.
Hongell K; Kurki S; Sumelahti ML; Soilu-Hänninen M
Mult Scler Relat Disord; 2019 Oct; 35():221-227. PubMed ID: 31404761
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence and prevalence of psoriasis in multiple sclerosis.
Marrie RA; Patten SB; Tremlett H; Wolfson C; Leung S; Fisk JD
Mult Scler Relat Disord; 2017 Apr; 13():81-86. PubMed ID: 28427708
[TBL] [Abstract][Full Text] [Related]
19. Validation of an algorithm for identifying MS cases in administrative health claims datasets.
Culpepper WJ; Marrie RA; Langer-Gould A; Wallin MT; Campbell JD; Nelson LM; Kaye WE; Wagner L; Tremlett H; Chen LH; Leung S; Evans C; Yao S; LaRocca NG;
Neurology; 2019 Mar; 92(10):e1016-e1028. PubMed ID: 30770432
[TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis epidemiology in Finland: Regional differences and high incidence.
Pirttisalo AL; Soilu-Hänninen M; Sipilä JOT
Acta Neurol Scand; 2019 Apr; 139(4):353-359. PubMed ID: 30480315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
